Objective: Although it may seem intuitive that obesity is an additional risk factor for surgical patients, few studies have correlated this condition with lung cancer resection. The only data currently available suggest that obesity does not increase the rate of complications after anatomic resection for non-small-cell lung cancer (NSCLC). . Ten patients died within the first 30 days (30-day mortality: 6.5%). The male sex was significantly more prevalent in the high BMI group ( p = 0.039). The preoperative mean creatinine value was significantly higher in the high BMI group (0.86 mg dl À1 vs 0.75 mg dl À1 , p = 0.002) and preoperative DLCO/AV values were better in the high BMI group than in the BMI group < 25 kg m À2 (79.9 vs 88.8, p = 0.009). The high BMI group had a higher incidence of respiratory complications (21.5% vs 4.9% p = 0.005, odds ratio (OR) = 5.3, 95% confidence interval (CI): 1.5, 18.7). No significant differences were observed between the two groups regarding ICU admission, hospital stay, 30-day mortality and total and specific cardiac complications. Conclusions: The risk of respiratory complications in patients with BMI higher than 25 kg m À2 undergoing pneumonectomy for lung cancer is 5.3 times higher than that of patients with BMI < 25 kg m
Introduction
Obesity is defined as 'abnormal or excessive fat accumulation that may impair health' [1] . Obesity is currently the most common metabolic disease in the world [2] with more than 1.6 billion overweight adults worldwide of whom at least 400 million are obese [1] .
Obesity and overweight are classified by the body mass index (BMI, kg m À2 ) devised by Lambert Adolphe Quetelet (1796-1874) in 1835. BMI is highly correlated with body fat and is therefore one of the easiest and most effective measures in clinical assessment and epidemiological studies [2] .
According to the World Health Organization (WHO) classification of BMI (Table 1) , a BMI between 18.5 and 24.9 kg m À2 is healthy in adults, a BMI between 25.0 and 29.9 kg m À2 is classed as overweight while a BMI greater than 30.0 kg m À2 is classed as obesity [1] . The WHO has estimated that around 2.3 billion adults will be overweight and more than 700 million obese by 2015 [1] . Epidemiological studies have suggested a significant inverse relationship between BMI and the incidence of lung cancer [3] [4] [5] , but it has only been with the recent epidemic of obesity that significant numbers of patients presenting for resection of non-small-cell lung cancer (NSCLC) have been overweight or obese [6] .
As complete anatomic resection remains the mainstay of attempted curative therapy for NSCLC in patients with locoregional disease [6] , it is quite common nowadays for thoracic surgeons and anaesthesiologists to manage overweight or obese patients eligible for standard or major curative lung resections.
Few series have described the influence of obesity on complications after anatomic resection for NSCLC [6, 7] mainly showing no impact of body weight either on postoperative death rates and poor surgical outcome or on early postoperative complications [. . .] .
The aim of our study was to assess the risk for overweight and obese patients undergoing pneumonectomy for curative therapy of NSCLC, and to evaluate the impact of BMI on 30-day mortality and early postoperative respiratory and overall complication rates.
Materials and methods

Aim
The study investigated the validity of the hypothesis that early postoperative mortality and morbidity rates after standard pneumonectomy are higher in overweight and obese patients compared with normal weight patients.
Population
Data were collected prospectively and entered into our institutional general thoracic database at the point of care and reviewed retrospectively.
From 1 January 2004 to 30 April 2008, 154 consecutive standard pneumonectomies for NSCLC were performed at the Department of Thoracic Surgery of the European Institute of Oncology. Standard pneumonectomy was defined as the intrapericardial or extrapericardial removal of the entire lung, associated with radical mediastinal lymph node dissection without any resection of mediastinal, chest wall or diaphragmatic structures [8] .
Patients already submitted to induction chemotherapy were enrolled in the present study (n = 80 patients, 51.9%), whereas patients receiving preoperative radiotherapy were excluded.
Patient selection and management
Operability was determined by standard clinical and radiographic procedures (whole-body computed tomography (CT scan)), nuclear imaging (whole-body 18 F-fluorodeoxyglucose (FDG)-positron emission tomography (PET scan)) and staging procedures including bronchoscopy, videomediastinoscopy and mediastinotomy as appropriate. We did not perform any redo mediastinoscopy. Preoperative respiratory function was assessed routinely by blood gas analysis, spirometry and lung perfusion scanning to identify the functionally prevalent lung; preoperative cardiac function evaluation was routinely performed by echocardiography with left ejection fraction (EF) and pulmonary artery pressure (PAP) estimate and tread-mill stress test; occasionally, the cardiopulmonary stress test was required for borderline patients to assess oxygen consumption.
Patients were always admitted the day before surgery unless they required preoperative management of medical co-morbidities, which was exceedingly uncommon.
Amoxicillin-clavulanic acid was administered for the first 5 postoperative days in non-allergic patients, with the first dose administered before skin incision. Intra-operative fluid administration was in the order of 5-7 ml kg À1 h À1 crystalloid infusion, not exceeding a total amount of 1500 ml in all cases. Ventilation was managed by a protective ventilation strategy (tidal volume 6 ml kg À1 , driving pressure < 20 cmH 2 O above the positive and negative expiratory pressure, permissive hypercapnia and the preferential use of pressure-limited ventilation modes [8] .
Thromboprophylaxis was maintained with sequential compression devices, early ambulation and low-molecularweight heparin delivered subcutaneously (sodic enoxaparin).
Postoperative analgesia was achieved, in conjunction with anaesthesiologists, using a combination of epidural analgesia (when technically feasible and not contraindicated), patientcontrolled analgesia (PCA) and oral and parenteral adjuncts as needed to improve pulmonary and physical therapy.
Patients were instructed preoperatively regarding incentive spirometry. Postoperatively, they received two assisted sessions of chest physiotherapy daily, starting on the first postoperative day, and were asked to repeat the physiotherapy programme six times during the day until discharge.
Therapeutic bronchoscopy was instituted early, based on clinical findings and correlation with daily chest films.
The thoracostomy tube (a standard 32 French thoracic drainage tube) was usually removed on the third postoperative day except in case of early complications such as bleeding, chylothorax or suspected early bronchopleural fistula.
Postoperative complications
Postoperative death was defined as the 30-day mortality rate or longer if mortality occurred during the index hospitalisation. Complications were classified as: (1) respiratory, (2) cardiac and (3) other complications. Respiratory complications were classified as follows: major complications (1) acute respiratory failure; (2) acute respiratory distress syndrome (ARDS); (3) acute lung injury (ALI); (4) pneumonia; (5) pulmonary embolism; and (6) pulmonary oedema; and 
Statistical methods
The summary statistics of patients' characteristics were tabulated either as number of patients (N), mean AE standard deviation (SD)
The mean BMI in patients with pulmonary complications was 27.7 AE 3.5 versus 26.1 AE 4.9 kg m À2 in patients without pulmonary complications; the p value (Mann-Whitney) was 0.076; however, the power of the test was only 39.9%, whereas the power of the comparison for the chi-square test for pulmonary complications is 81.0%.
Data were analysed using SAS 9.1.3 Service Pack 4 (SAS Institute Inc., Cary, NC, USA) and STATA/IC 10 for Windows (STATA Corp., TX, USA).
Results
Population
During the study period, 154 patients underwent pneumonectomy for NSCLC, of whom 124 (80.5%) were men. The overall mean age was 63.5 years (range: 36-82). There were 64 (41.5%) right and 90 (58.5%) left pneumonectomies.
As many as 136 patients (88.3%) were smokers or former smokers at the time of diagnosis. The mean preoperative albumin value was 4.1 g dl À1 (range: 2.5-5.2), the mean preoperative total protein value was 7.2 g dl À1 (range: 5.4-8.8) and the mean preoperative creatinine value was 0.81 mg dl À1 (range: 0.45-1.9). Eighty patients (51.9%) received induction chemotherapy; the pathological stage and clinical characteristics of the population are listed in Table 2 .
The mean percentage predicted value of the preoperative forced expiratory volume in 1 s (FEV1) was 83.5 AE 19.2 and the carbon monoxide lung diffusion capacity (DLCO) divided by the alveolar volume (AV) (DLCO/AV) was 85.4 AE 20.3.
Median hospital stay and intensive care unit (ICU) stay were 6 days (range: 4-48) and 0 days (range: 0-38), respectively.
The male sex was significantly more frequent in the high BMI group ( p = 0.04). Preoperative DLCO/AV in the high BMI group was slightly better than in the BMI < 25 kg m À2 group (88.9 AE 21.5 vs 79.9 AE 17.1, p = 0.006), as already reported in the literature [6] .
Preoperative mean creatinine value was significantly higher in the high BMI group compared with the BMI group < 25 kg m À2 (0.86 AE 0.25 g dl -1 vs 0.74 AE 0.19 g dl À1 , p = 0.002).
No statistically significant difference between the two groups was evident in terms of age ( p = 0.51), cigarette smoking ( p = 0.46), preoperative albumin ( p = 0.14) and total protein value ( p = 0.43), preoperative FEV1 ( p = 0.14), side of the operation ( p = 0.07), histology ( p = 0.61) and pathological state ( p = 0.29) ( Table 2 ).
Mortality, morbidity and complications
Ten patients (6%) died within the first 30 days. Three patients belonged to the group with BMI < 25 kg m À2 . Causes of death were cardiogenic shock in two cases; and one patient died at home 3 days after discharge without any clear cause. Seven deceased patients belonged to the high BMI group: four patients died after respiratory failure, two patients died from cardiogenic shock and one patient died at home 2 days after discharge without any clear cause.
Respiratory complications were significantly more frequent in the high BMI group (21.5% vs 4.9%, crude OR = 5.29; 95% CI: 1.50, 18.70). This difference remained significant Table 3 ). In the 'underweight group', we observed 0/5 pulmonary complication (0%); and in the 'normal weight' group, we observed 3/56 pulmonary complications (5.3%).
In the 'overweight' group, we observed 16/66 pulmonary complications (24.2%); in the obesity class I group, we observed 3/19 pulmonary complications (15.8%); in the obesity class II group, we observed 1/7 pulmonary complication (14.2%); and in the obesity class III group, we observed 0/ 1 pulmonary complication (0%) (Fig. 1) .
In the higher BMI group, we had 20 patients with respiratory complications; they were pneumonia in eight cases; ARDS in three cases; pulmonary embolism in two cases; acute respiratory failure in four cases; and atelectasis in three cases.
In the group with BMI < 25 kg m
À2
, we had three patients with respiratory complications; they were two cases of atelectasis and one case of pneumonia.
We had only five patients belonging to the underweight group; none of them experienced pulmonary or cardiac complication, but three of them (60%) had anaemisation during the postoperative period and required red blood cell transfusion.
We had 26 patients with BMI > 30 kg m À2 ; among them were four cases of pulmonary complications (11.5%); among the 128 patients with BMI < 30 kg m À2 , we had 20 pulmonary complications (15.6%); Fisher's exact test did not show any significant difference ( p = 0.77).
Moreover, we had 67 patients with BMI between 24.99 and 29.99 kg m À2 (overweight) with 17 pulmonary complications (25.3%); no significant difference was observed when compared with the 'obese' group ( p = 0.17).
Regarding pulmonary complications we had: right pneumonectomy (17/89) 19.0%: and left pneumonectomy 6/64 (9.3%). Regarding postoperative deaths, we had: right pneumonectomy (4/89) 4.5%; and left pneumonectomy (6/ 64) 9.3% (Fig. 2(A) and (B) ) There were no statistically significant differences either in terms of pulmonary complications ( p = 0.097) or in terms of postoperative deaths ( p = 0.23) (Fig. 3) .
No significant difference between the two groups was evident in terms of 30-day mortality (OR = 1.57; 95% CI: 0.39, 9.78), total hospital stay ( p = 0.21), ICU stay ( p = 0.53) and overall (OR = 1.26; 95% CI: 0.62, 2.55), cardiac (OR = 1.45; 95% CI: 0.65, 3.30) and other complications (including surgical/technical complications, neurological complications and abdominal/urinary tract complications, OR = 0.85; 95% CI: 0.42, 1.73) ( Table 3 ).
Discussion
Nutritional status is known to influence postoperative morbidity in patients undergoing gastrointestinal surgery, oesophageal surgery and lung cancer surgery [7] . Although several investigators have demonstrated that weight and relative weight are inversely associated with the risk of lung cancer [13, 14] , recent studies found a low incidence of low BMI in operable lung cancer [13] and the majority of operable lung cancer patients were over-rather than underweight [7] . This finding is most likely due to two conditions: (1) operable patients are often in the early and mainly not-advanced stages of lung cancer rather than the late cachectic stage; and (2) with the recent epidemic of obesity in industrialised countries, significant proportions of patients presenting for the resection of NSCLC are overweight or obese.
In 2002, it was estimated that 1.35 million people throughout the world were diagnosed with lung cancer, and 1.18 million died from lung cancer more than any other type of cancer [14] .
Considering that complete anatomical resection remains the mainstay of attempted curative therapy for NSCLC in patients with loco-regional disease, and that both obesity and lung cancer are ongoing epidemics in industrialised countries, it is now quite common for thoracic surgeons and anaesthesiologists to manage overweight or obese patients eligible for standard or major curative lung resections. Our high BMI group comprised more men than women ( p = 0.04). This observation is partially in contrast with the prevalence of obesity in the standard population, where the female gender is often more predominant, although multifactorial aspects have to be considered in this disease (e.g., social, ethnic and cultural factors) [15] .
Overweight and obese patients pose a significant challenge for intra-and postoperative management, mainly in major pulmonary resections such as pneumonectomy, thus explaining why surgeons and anaesthesiologists may be reluctant to operate on this subset of patients.
Our results clearly suggest that overweight and obese patients present a higher pulmonary complication rate than do normal weight patients: increased intra-operative difficulties, frequent bleeding complications, co-morbidities and impaired preoperative pulmonary function may justify this result. Interestingly, cardiac complications were infrequent in the overweight group. This may be basically due to two factors: (1) cardiac complications after pneumonectomy frequently consist of rhythm disorders rather than ischaemic disease and are strictly related to technical procedures (pericardial opening, deep vascular dissection and postoperative electrolyte depletion) rather than the patient's clinical status; and (2) the strict preoperative enrolment criteria, mainly for obese patients, with echocardiography evaluation and stress test when indicated, select ideal patients for the planned pneumonectomy, thus excluding severely compromised patients.
Although intuitive, it has not hitherto been demonstrated that pulmonary complications are fivefold more frequent in overweight patients. This seems to be closely related to the chronic preoperative precarious situation of the patients, suddenly modified by the acute surgical event. Several mechanisms have been proposed to explain pulmonary abnormalities in obese patients: obesity-induced abnormal respiratory system mechanics, impaired central responses to hypercapnia and hypoxia, sleep-disordered breathing and neurohormonal abnormalities such as leptin resistance [16] . Obesity imposes a significant mechanical load leading to a reduction in total respiratory system compliance, increased lung resistance and a relative state of respiratory muscle weakness leading to increased work of breathing [17] [18] [19] . Surprisingly in our series, as already reported in the literature [6] , high BMI patients presented a better DLCO/ AV. This situation has been attributed to the lower incidence of active smokers in the obese population, whereas smoking habits were very similar in our two groups (88.5% vs 92.1%, p = 0.46) and cannot justify this anomalous result. We consider that our high BMI patients had a better DLCO/AV because of a reduced AV in the obese population rather than to an increase in DLCO. Unadjusted DLCO for AV was only slightly better in the overweight group; however, no statistical significant difference was observed. We preferred to use DLCO/AV values rather than DLCO because it has been proven that DLCO/AV might represent a more accurate expression of the intrinsic gas exchange function of the lung [20, 21] .
We decided to consider as the cut-off value 25 kg m À2 and not 30 kg m À2 , thus focusing on overweight and not only obese patients for two main reasons:
(1) The overweight population is much larger than the obese one and so the probability of a thoracic surgeon to operate on overweight patients and to cope with their complications is much higher when compared with obese ones. (2) If we had used the 30 kg m À2 cut-off value, the takehome message would have been that only obese patients are at higher risk for pulmonary complications, thus giving the misleading impression that overweight patients are not at higher risk, while our results do suggest that they are.
The preoperative mean creatinine value was significantly higher in the high BMI group (0.86 mg dl À1 vs 0.75 mg dl Pulmonary complications in overweight and obese patients were routinely treated as in patients with a BMI lower than 25 kg m À2 with the exception of several drugs requiring a higher posology (e.g., low-molecular-weight heparin, antibiotics and so on).
The postoperative course was not influenced in terms of ICU stay, probably because pulmonary complications were experienced after discharge from ICU (where the patient usually stayed only during postoperative days 0 and 1) and they were effectively treated in the ward, with the only rare exception of patients requiring reintubation.
Given the high-risk background of this subset of patients, meticulous management of postoperative fluid administration is crucial and daily weight control and central venous pressure measurement are mandatory to avoid fluid overflow or, on the other hand, renal failure.
Conclusion
Respiratory complications after standard pneumonectomy for curative resection of NSCLC are fivefold more frequent in overweight and obese patients than in subjects with BMI < 25 kg m À2 . No statistical difference was observed regarding cardiac complications and 30-day mortality rate.
Overweight and obesity represent additional risk factors for patients requiring pneumonectomy and should be entertained by thoracic surgeons and anaesthesiologists before planning pulmonary resection.
